Curis | CRIS - Ebit





Ebit Изменить Дата
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
CSL USD 2.64B 116M 2025-12
Curis USD -12.37M 230K 2023-09
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.44M 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 257.49B 568.56B 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12
Verastem USD -37.03M 6M 2024-09
Xoma USD -10.08M 4.4M 2024-06